Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.22.2.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Deferred financing cost $ 2,250,171 $ 2,091,732
Common units, Authorized   1,000,000
Common units, Issued   34,182
Common units, Outstanding   34,182
Class A    
Common stock , par value $ 0.001  
Common stock , Authorized 160,000,000  
Common stock , shares issued 3,260,364  
Common stock , shares outstanding 3,260,364  
Class B    
Common stock , par value $ 0.001  
Common stock , Authorized 20,000,000  
Common stock , shares issued 11,278,000  
Common stock , shares outstanding 11,278,000